메뉴 건너뛰기




Volumn 28, Issue 17, 2010, Pages

Reply to B.I. Rini et al

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; HAPTOGLOBIN; LACTATE DEHYDROGENASE; PLACEBO; SUNITINIB; VASCULOTROPIN;

EID: 79951803626     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.3037     Document Type: Letter
Times cited : (1)

References (3)
  • 1
    • 77956395910 scopus 로고    scopus 로고
    • Toxicity of sunitinib plus bevacizumab in renal cell carcinoma
    • Rini BI, Garcia JA, Cooney MM, et al: Toxicity of sunitinib plus bevacizumab in renal cell carcinoma. J Clin Oncol 28:e284-e285, 2010
    • (2010) J Clin Oncol , vol.28
    • Rini, B.I.1    Garcia, J.A.2    Cooney, M.M.3
  • 2
    • 70349673595 scopus 로고    scopus 로고
    • A phase I study of sunitinib plus bevacizumab in advanced solid tumors
    • Rini BI, Garcia JA, Cooney MM, et al: A phase I study of sunitinib plus bevacizumab in advanced solid tumors. Clinical Cancer Res 15:6277-6283, 2009
    • (2009) Clinical Cancer Res , vol.15 , pp. 6277-6283
    • Rini, B.I.1    Garcia, J.A.2    Cooney, M.M.3
  • 3
    • 63049093371 scopus 로고    scopus 로고
    • Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
    • Feldman DR, Baum MS, Ginsberg MS, et al: Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol 27:1432-1439, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 1432-1439
    • Feldman, D.R.1    Baum, M.S.2    Ginsberg, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.